James Inglese, PhD, heads a laboratory focused on the development of assay and screening technology within the National Center for Advancing Translational Science and is an adjunct investigator at the National Human Genome Research Institute. Prior to this he co-founded the National Institutes of Health (NIH) Chemical Genomics Center, acting as its deputy director. Dr. Inglese received his PhD in organic chemistry from the Pennsylvania State University and completed postdoctoral training in the laboratory of Prof. Robert J. Lefkowitz at Duke University Medical Center. Before going to the NIH, Dr. Inglese led research teams at the Princeton-based biotech Pharmacopeia and Merck Research Laboratories. Over the past two decades, Dr. Inglese has contributed to over 150 publications and patents. Dr. Inglese is the founding editor (2002) and editor-in-chief of ASSAY and Drug Development Technologies and serves on the scientific advisory boards of several NIH-funded chemistry and screening centers and international chemical biology consortia.